- Home
- NNNN vs EFSC Comparison
NNNN vs EFSC Comparison
Compare NNNN & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- EFSC
- Stock Information
- Founded
- NNNN 2021
- EFSC 1988
- Country
- NNNN Germany
- EFSC United States
- Employees
- NNNN N/A
- EFSC N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EFSC Major Banks
- Sector
- NNNN Health Care
- EFSC Finance
- Exchange
- NNNN Nasdaq
- EFSC Nasdaq
- Market Cap
- NNNN 2.2B
- EFSC 2.1B
- IPO Year
- NNNN 2025
- EFSC 1999
- Fundamental
- Price
- NNNN $45.65
- EFSC $60.64
- Analyst Decision
- NNNN
- EFSC Strong Buy
- Analyst Count
- NNNN 0
- EFSC 3
- Target Price
- NNNN N/A
- EFSC $64.33
- AVG Volume (30 Days)
- NNNN 88.1K
- EFSC 137.0K
- Earning Date
- NNNN 01-01-0001
- EFSC 10-20-2025
- Dividend Yield
- NNNN N/A
- EFSC 2.05%
- EPS Growth
- NNNN N/A
- EFSC 15.35
- EPS
- NNNN 0.06
- EFSC 5.26
- Revenue
- NNNN $8,185,146.00
- EFSC $637,581,000.00
- Revenue This Year
- NNNN N/A
- EFSC $18.12
- Revenue Next Year
- NNNN N/A
- EFSC $4.60
- P/E Ratio
- NNNN $839.78
- EFSC $11.52
- Revenue Growth
- NNNN 21.95
- EFSC 9.46
- 52 Week Low
- NNNN $5.18
- EFSC $45.22
- 52 Week High
- NNNN $55.65
- EFSC $63.13
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- EFSC 64.60
- Support Level
- NNNN N/A
- EFSC $56.38
- Resistance Level
- NNNN N/A
- EFSC $62.30
- Average True Range (ATR)
- NNNN 0.00
- EFSC 1.38
- MACD
- NNNN 0.00
- EFSC 0.39
- Stochastic Oscillator
- NNNN 0.00
- EFSC 72.70
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.